Utility of a single mid-trimester measurement of plasminogen activator Type 1 and fibronectin to predict preeclampsia in pregnancy.

Simple item page
dc.contributor.authorAjibola, S.O.
dc.contributor.authorAdeyemo, T.A.
dc.contributor.authorAfolabi, B.B.
dc.contributor.authorAkanmu, A.S.
dc.date.accessioned2020-09-09T14:47:40Z
dc.date.available2020-09-09T14:47:40Z
dc.date.issued2016-08
dc.description.abstractPreeclampsia (PE) is the second most common cause of maternal death after obstetric hemorrhage in Africa, a resource-limited region. This study was designed to examine the potential usefulness of a single screening plasma plasminogen activator inhibitor-1 (PAI-1) and fibronectin (FN) level for the prediction of PE in pregnant women.en_US
dc.identifier.citationAjibola SO, Adeyemo TA, Afolabi BB, Akanmu AS. Utility of a single mid-trimester measurement of plasminogen activator Type 1 and fibronectin to predict preeclampsia in pregnancy. Niger Med J. 2016 Jul-Aug;57(4):213-6. doi: 10.4103/0300-1652.188337. PubMed PMID: 27630384; PubMed Central PMCID: PMC4995812.en_US
dc.identifier.urihttps://ir.unilag.edu.ng/handle/123456789/8824
dc.language.isoenen_US
dc.publisherNiger Med J.en_US
dc.subjectFibronectinen_US
dc.subjectPlasminogenen_US
dc.subjectActivator inhibitor-1en_US
dc.subjectPreeclampsiaen_US
dc.titleUtility of a single mid-trimester measurement of plasminogen activator Type 1 and fibronectin to predict preeclampsia in pregnancy.en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
AFOLABI Utility of a single mid-trimester measurement of plasminogen activator Type 1 and fibronectin to predict preeclampsia in pregnancy..pdf
Size:
986.9 KB
Format:
Adobe Portable Document Format
Description:
Original article
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Obstetrics and Gynaecology- Scholarly Publications